233 related articles for article (PubMed ID: 27147338)
21. Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner.
Visvikis D; Griffiths D; Costa DC; Bomanji J; Ell PJ
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1050-6. PubMed ID: 15846487
[TBL] [Abstract][Full Text] [Related]
22. Unexpected Abnormal Uptake in the Breasts at Dedicated Breast PET: Incidentally Detected Small Cancers or Nonmalignant Features?
Satoh Y; Motosugi U; Omiya Y; Onishi H
AJR Am J Roentgenol; 2019 Feb; 212(2):443-449. PubMed ID: 30476450
[TBL] [Abstract][Full Text] [Related]
23. Performance comparison of a dedicated total breast PET system with a clinical whole-body PET system: a simulation study.
Samanta S; Jiang J; Hamdi M; Register AZ; Majewski S; Williams MB; Turkington TG; Tornai MP; Laforest R; O'Sullivan JA; Tai YC
Phys Med Biol; 2021 May; 66(11):. PubMed ID: 33892480
[TBL] [Abstract][Full Text] [Related]
24. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
[TBL] [Abstract][Full Text] [Related]
25. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography.
Koga H; Sasaki M; Kuwabara Y; Nakagawa M; Hayashi K; Kaneko K; Chen T; Honda H
Ann Nucl Med; 2004 Apr; 18(2):131-6. PubMed ID: 15195760
[TBL] [Abstract][Full Text] [Related]
26. Performance evaluation of a whole-body prototype PET scanner with four-layer DOI detectors.
Akamatsu G; Tashima H; Iwao Y; Wakizaka H; Maeda T; Mohammadi A; Takyu S; Nitta M; Nishikido F; Rutherford H; Chacon A; Safavi-Naeini M; Yoshida E; Yamaya T
Phys Med Biol; 2019 Apr; 64(9):095014. PubMed ID: 30978704
[TBL] [Abstract][Full Text] [Related]
27. Super-resolution in PET imaging.
Kennedy JA; Israel O; Frenkel A; Bar-Shalom R; Azhari H
IEEE Trans Med Imaging; 2006 Feb; 25(2):137-47. PubMed ID: 16468448
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of optimized injection dose and acquisition time using body mass index for three-dimensional whole-body FDG-PET].
Matsumoto K; Matsuura H; Minota E; Sakamoto S; Nakamoto Y; Senda M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2004 Nov; 60(11):1564-73. PubMed ID: 15568009
[TBL] [Abstract][Full Text] [Related]
29. Deep Inspiration Breath Hold [(18)F]FDG PET-CT on 4-rings scanners in evaluating lung lesions: evidences from a phantom and a clinical study.
Caobelli F; Puta E; Kaiser SR; Massetti V; Andreoli M; Mostarda A; Soffientini A; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):136-47. PubMed ID: 24268841
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose.
Paul AK; Tatsumi M; Fujino K; Hashikawa K; Nishimura T
Eur J Nucl Med; 2001 Nov; 28(11):1697-701. PubMed ID: 11702113
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
Masumoto N; Kadoya T; Sasada S; Emi A; Arihiro K; Okada M
Breast Cancer Res Treat; 2018 Sep; 171(2):315-323. PubMed ID: 29779072
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
Sasada S; Kimura Y; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
Eur J Surg Oncol; 2021 Jul; 47(7):1588-1592. PubMed ID: 33685728
[TBL] [Abstract][Full Text] [Related]
33. Image quality evaluation of real low-dose breast PET.
Satoh Y; Imai M; Ikegawa C; Onishi H
Jpn J Radiol; 2022 Nov; 40(11):1186-1193. PubMed ID: 35612727
[TBL] [Abstract][Full Text] [Related]
34. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
Eur J Surg Oncol; 2018 Apr; 44(4):444-448. PubMed ID: 29396328
[TBL] [Abstract][Full Text] [Related]
35. Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.
Koolen BB; Vidal-Sicart S; Benlloch Baviera JM; Valdés Olmos RA
Nucl Med Commun; 2014 May; 35(5):446-52. PubMed ID: 24686195
[TBL] [Abstract][Full Text] [Related]
36. Quantitative image reconstruction for total-body PET imaging using the 2-meter long EXPLORER scanner.
Zhang X; Zhou J; Cherry SR; Badawi RD; Qi J
Phys Med Biol; 2017 Mar; 62(6):2465-2485. PubMed ID: 28240215
[TBL] [Abstract][Full Text] [Related]
37. Impact of target-to-background ratio, target size, emission scan duration, and activity on physical figures of merit for a 3D LSO-based whole body PET/CT scanner.
Brambilla M; Matheoud R; Secco C; Sacchetti G; Comi S; Rudoni M; Carriero A; Inglese E
Med Phys; 2007 Oct; 34(10):3854-65. PubMed ID: 17985631
[TBL] [Abstract][Full Text] [Related]
38. Dedicated breast PET value to evaluate BI-RADS 4 breast lesions.
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares A; Ruibal A; Vázquez-Caruncho M
Eur J Radiol; 2018 Nov; 108():201-207. PubMed ID: 30396656
[TBL] [Abstract][Full Text] [Related]
39. Variability of lesion detectability and standardized uptake value according to the acquisition procedure and reconstruction among five PET scanners.
Takahashi Y; Oriuchi N; Otake H; Endo K; Murase K
Ann Nucl Med; 2008 Jul; 22(6):543-8. PubMed ID: 18670864
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of dedicated breast positron emission tomography.
Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S
Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
